GHRL and Thrombocytopenia: Seemingly, these results provide evidence that ghrelin therapy can improve CI-survival and recovery via (at least in part) ameliorating the damage to lymphoid tissues and attenuating the effects of leukocytopenia and thrombocytopenia [23].